- Analysis of indicators in cellular and hymoral immune system in women with parvovyrus infection in various periodsof pregnancy
Analysis of indicators in cellular and hymoral immune system in women with parvovyrus infection in various periodsof pregnancy
HEALTH OF WOMAN. 2017.9(125):117–121; doi 10.15574/HW.2017.125.117
Bondarenko N. P.
A.A. Bogomolets National Medical University, Kiev
The article covers the topic Parvovirus infection in pregnant women caused the development of immunopathological reactions. 129 in fected pregnant women and 16 women with physiological pregnancy in the 1st, 2nd and 3rd trimesters were examined. In infected pregnant women, activation of the cellular level of immunity was observed, a significant increase in the number of natural killers in the peripheral blood and an increase in the immunoregulatory index were detected, with greater deviations from the control indicators found in the 1st trimester. In pregnant women, in which clinical complications were noted, the population composition of lymphocytes was characterized by an increased number of NK cells, low infection with the number of cytotoxic CD8+-lymphocytes and a shift in the ratio of CD4+/CD8+totheside, which indicates an increase in helper mechanisms. Increasing the number of T-lymphocytes, T-helpercells, NK/Т cellsandactivated CD25+-lymphocytes in pregnant women with out clinical complications at different periods of pregnancy can contribute to effective elimination of the virus and to prevent severe fetal lesions. Violation of the humoral link of the immune system in the infection of pregnant parvovirus infection was shown in an increase in the serum IgM content in different periods of pregnancy (by 79.1%, 54.2% and 38.5%), and a decrease in IgA levels in the 1st and 2nd trimesters (p>0.05), to a greater extent such changes were found in women with clinical complications of pregnancy and especially in the first trimester.
Key words: pregnancy, parvovirusinfection, cellular and humoral immunity.
1. Lutsenko MT. 2011. Gibel zarodysha i ploda pri obostrenii gerpesvirusnoy infektsii. Byul. fiziologii i patologii dykhaniya. Vyp. 42:59–64.
2. Vasilyev VV. Murina EA. Sidorenko SV i dr. 2011. Parvovirusnaya (V19V) infektsiya u beremennykh i detey rannego vozrasta. Zh. infektologii 3;4:26–33.
3. Rebrova OYu. 2006. Statisticheskiy analiz meditsinskikh dannykh. Primeneniye paketa prikladnykh programm STATISTICA. M. Media Sfera:312. (3-e izd.-iye).
4. Heegaard ED, Brown KE. 2002. Human parvovirus B19. Clinical microbiology reviews. 15(3):485-505. https://doi.org/10.1128/CMR.15.3.485-505.2002; PMCid:PMC118081
5. Klenerman P, Tolfvenstam T, Price DA et al. 2002. T-lymphocyte responses against human parvovirus B19: smallvirus, bigresponse. Pathol. Biol. 50:317–325. https://doi.org/10.1016/S0369-8114(02)00306-1
6. Mor G, Cardenas I. 2010. The immune system in pregnancy: a uniquecomplexity. Am. J. Reprod. Immunol. 63(6):425–433. https://doi.org/10.1111/j.1600-0897.2010.00836.x; PMid:20367629 PMCid:PMC3025805
7. Lamont RF, Sobel JD, Vaisbuch E et al. 2011. Parvovirus B19 infection in human pregnancy. BJOG: an International Journal of Obstetrics and Gynaecology. 118(2):175–186. https://doi.org/10.1111/j.1471-0528.2010.02749.x; PMid:21040396 PMCid:PMC3059196
8. Servey JT, Reamy BV, Hodge J. 2007. Clinical presentations of parvovirus B19 infection. Am. Fam. Physician. 75(3):373–376. PMid:17304869